Literature DB >> 19719161

Hybrid nanospheres and vesicles based on pectin as drug carriers.

Cui-Yun Yu1, Han Cao, Xi-Chen Zhang, Fang-Zhou Zhou, Si-Xue Cheng, Xian-Zheng Zhang, Ren-Xi Zhuo.   

Abstract

A novel strategy was developed to prepare nanospheres and vesicles as drug carriers. The drug-loaded pectin nanospheres and vesicles were fabricated in aqueous media containing Ca2+ and CO3(2-) ions under very mild conditions, which did not involve any surfactant. Through adjusting the preparation conditions, nanosized drug delivery systems with diverse morphologies, that is, nanospheres and vesicles, could be obtained. This technique could offer good control over the morphology and the size of nanospheres and vesicles. The morphologies of the aggregates were observed by environmental scanning electron microscopy and transmission electron microscopy. 5-Fluorouracil (5-FU), an antineoplastic drug, was encapsulated in the nanospheres and vesicles, and the in vitro drug release at different pH values was investigated. With the presence of Ca2+ and CO3(2-) ions in the pectin-based nanospheres/vesicles, the release of the low molecular weight drug could be effectively sustained from the highly hydrolyzed polysaccharide-based drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719161     DOI: 10.1021/la901389v

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  8 in total

1.  Characterization of self-organized TiO2 nanotubes on Ti-4Zr-22Nb-2Sn alloys and the application in drug delivery system.

Authors:  Y Q Liang; Z D Cui; S L Zhu; X J Yang
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

2.  Microfluidic formulation of pectin microbeads for encapsulation and controlled release of nanoparticles.

Authors:  D Ogończyk; M Siek; P Garstecki
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

3.  Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy.

Authors:  Raj Kumar Dutta; Saurabh Sahu
Journal:  Results Pharma Sci       Date:  2012-05-22

4.  Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.

Authors:  Meng-Qing Gong; Cong Wu; Xiao-Yan He; Jing-Yi Zong; Jin-Long Wu; Ren-Xi Zhuo; Si-Xue Cheng
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

5.  Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.

Authors:  Jianing Meng; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Sci       Date:  2011-06-17       Impact factor: 4.384

6.  Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin-doxorubicin conjugates macromolecular pro-drug for targeted cancer therapy.

Authors:  Zhi-Ping Li; Ming-Chao Jiang; Bo Chen; Pei Gao; Sa Yang; Yu-Feng Liu; Peng-Ju Ye; Dong-Xiu He; Hong-Lin Huang; Cui-Yun Yu
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

7.  In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.

Authors:  Can Huang; Na-Mei Li; Pei Gao; Sa Yang; Qian Ning; Wen Huang; Zhi-Ping Li; Peng-Ju Ye; Li Xiang; Dong-Xiu He; Xiang-Wen Tan; Cui-Yun Yu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil.

Authors:  M Biswaranjan Subudhi; Ankit Jain; Ashish Jain; Pooja Hurkat; Satish Shilpi; Arvind Gulbake; Sanjay K Jain
Journal:  Materials (Basel)       Date:  2015-02-27       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.